Works matching IS 1007385X AND DT 2025 AND VI 32 AND IP 1

Results: 16

新型抗体偶联药物治疗多线治疗后进展的铂耐药性卵巢癌1例及文献复习.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 115, doi. 10.3872/j.issn.1007-385x.2025.01.016

By:

殷姿;
丽萍;
周凡;
卢慧;
包金枫;
朱丽晶;
刘宝瑞

Publication type:

Article

肿瘤相关高内皮微静脉在肿瘤中的作用及其临床意义.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 107, doi. 10.3872/j.issn.1007-385x.2025.01.015

By:

李云康;
赵立仙;
潘云

Publication type:

Article

CHPF在上皮源性恶性肿瘤中的作用及其分子机制研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 101, doi. 10.3872/j.issn.1007-385x.2025.01.014

By:

潘强锋;
宣兰兰

Publication type:

Article

肿瘤细胞与CD8<sup>+</sup> T细胞状态的缠绕关系决定免疫治疗的动态反应.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 94, doi. 10.3872/j.issn.1007-385x.2025.01.013

By:

薛畅综;
黄英丹;
吴静怡

Publication type:

Article

KHSRP靶向调控JAK1/STAT3 信号通路对食管胃结合部腺癌恶性生物学行为的影响.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 38, doi. 10.3872/j.issn.1007-385x.2025.01.006

By:

张海峰;
王梦瑶;
王晓龙;
刘洋洋;
李丽;
韦海涛

Publication type:

Article

肿瘤肺转移前微环境的研究进展及靶向治疗策略.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 85, doi. 10.3872/j.issn.1007-385x.2025.01.012

By:

杨轩;
顾炎

Publication type:

Article

PD-1 单抗联合化疗对非小细胞肺癌患者淋巴细胞亚群的影响及疗效和预后的相关分析

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 73, doi. 10.3872/j.issn.1007-385x.2025.01.010

By:

吕青芳;
张鹏;
李桂香

Publication type:

Article

METTL3 介导的m6A修饰调控miR-1224-5p 在前列腺癌细胞增殖和迁移中的作用.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 64, doi. 10.3872/j.issn.1007-385x.2025.01.009

By:

胡东来;
赵梓岐;
楚元奎

Publication type:

Article

MAT2A抑制剂阻断食管鳞状细胞癌进展及其对下游信号网络的影响.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 56, doi. 10.3872/j.issn.1007-385x.2025.01.008

By:

肖远帆;
陈杰

Publication type:

Article

PTPRD去甲基化通过PI3K/Akt/mTOR通路调控胃癌细胞的增殖、迁移及化疗耐药性.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 48, doi. 10.3872/j.issn.1007-385x.2025.01.007

By:

刘妍慧;
高紫玉;
任鹏b;
杜予馨;
刘彩霞;
邢智伟

Publication type:

Article

iSEND免疫评分联合LIPI在评估非小细胞肺癌免疫治疗预后中的价值.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 79, doi. 10.3872/j.issn.1007-385x.2025.01.011

By:

江山;
王乐朋;
陈大川;
岳春芽;
蓝楠

Publication type:

Article

乙酰化修饰在甲状腺癌发生发展中的作用及其潜在的临床应用价值.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 30, doi. 10.3872/j.issn.1007-385x.2025.01.005

By:

梁楠;
敖倩;
孙辉

Publication type:

Article

小细胞肺癌免疫治疗: 进展与挑战.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 14, doi. 10.3872/j.issn.1007-385x.2025.01.003

By:

廖成功;
张贺龙

Publication type:

Article

CAR-T细胞治疗的临床关键问题和对策.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 9, doi. 10.3872/j.issn.1007-385x.2025.01.002

By:

陈新峰;
刘莎莎

Publication type:

Article

免疫细胞介导的药物递送系统.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 24, doi. 10.3872/j.issn.1007-385x.2025.01.004

By:

李从文;
储以微

Publication type:

Article

CAR-NK细胞治疗实体瘤的现状、机遇与挑战.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 1, doi. 10.3872/j.issn.1007-385x.2025.01.001

By:

刘艳芳

Publication type:

Article